Safety of Ixekizumab in Patients With Psoriatic Arthritis: Results From a Pooled Analysis of Three Clinical Trials

OBJECTIVE: To evaluate ixekizumab safety in adults with psoriatic arthritis (PsA). METHODS: Safety data from 2 integrated data sets are presented: 1) 24‐week, double‐blind, placebo‐controlled period of SPIRIT‐P1 and SPIRIT‐P2; and 2) all ixekizumab‐treated patients of SPIRIT‐P1 and SPIRIT‐P2 plus SP...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Arthritis Care Res (Hoboken)
Main Authors: Mease, Philip, Roussou, Euthalia, Burmester, Gerd‐Rüdiger, Goupille, Philippe, Gottlieb, Alice, Moriarty, Susan R., Benichou, Olivier, Adams, David H., Xu, Wen, Nash, Peter
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Psoriatic Arthritis
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6593968/
https://ncbi.nlm.nih.gov/pubmed/30156760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acr.23738
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados